A retrospective review of 61 patients with antiphospholipid syndrome: Analysis of factors influencing recurrent thrombosis

Sanja Krnic-Barrie, Carolyn Riester O'Connor, Stephen W. Looney, Silvia S. Pierangdi, E. Nigel Harris

Research output: Contribution to journalArticle

192 Citations (Scopus)

Abstract

Background: Antiphospholipid syndrome (APS) is a disorder of recurrent venous or arterial thrombosis, pregnancy losses, and thrombocytopenia. Recurrent thrombosis has particularly adverse effects on patient prognosis. The factors that influence recurrence and management techniques that prevent these events remain controversial. To add further insight regarding predisposing factors and the prevention of thrombotic recurrence, 61 well- characterized patients with APS were followed up for a median time of 77 months. Methods: A retrospective cohort study was conducted in which the following factors were examined to determine their influence on thrombotic recurrence: primary vs secondary syndrome; the presence of hypertension, hyperlipidemia, diabetes, or smoking; patient age, sex, and race; pregnancy and oral contraceptives use; and treatment with warfarin sodium, warfarin plus aspirin, aspirin alone, prednisone, or no treatment. Results: There was no difference between patients with primary and secondary APS with respect to recurrent arterial (55% vs 38%, respectively) or recurrent venous (47% vs 50%, respectively) thrombotic events. In all patients with APS, white race (P=.02) was associated with recurrent arterial events. Venous thrombosis occurred during pregnancy or in the postpartum period in 16 (30%) of 53 women and in 8 women taking oral contraceptives. Recurrent arterial and venous thromboses were significantly decreased with prophylactic warfarin use when compared with prednisone use or no treatment. Recurrences were infrequent in patients with prothrombin ratios of 1.5 to 2.0. Conclusions: Treatment with warfarin was most effective in preventing recurrent arterial and venous thrombosis. Pregnancy and the use of oral contraceptives or prednisone may also influence recurrence.

Original languageEnglish (US)
Pages (from-to)2101-2108
Number of pages8
JournalArchives of Internal Medicine
Volume157
Issue number18
StatePublished - Oct 20 1997
Externally publishedYes

Fingerprint

Antiphospholipid Syndrome
Statistical Factor Analysis
Thrombosis
Warfarin
Recurrence
Oral Contraceptives
Prednisone
Venous Thrombosis
Pregnancy
Aspirin
Prothrombin
Therapeutics
Hyperlipidemias
Causality
Thrombocytopenia
Postpartum Period
Cohort Studies
Retrospective Studies
Smoking
Hypertension

ASJC Scopus subject areas

  • Internal Medicine

Cite this

A retrospective review of 61 patients with antiphospholipid syndrome : Analysis of factors influencing recurrent thrombosis. / Krnic-Barrie, Sanja; O'Connor, Carolyn Riester; Looney, Stephen W.; Pierangdi, Silvia S.; Harris, E. Nigel.

In: Archives of Internal Medicine, Vol. 157, No. 18, 20.10.1997, p. 2101-2108.

Research output: Contribution to journalArticle

Krnic-Barrie, Sanja ; O'Connor, Carolyn Riester ; Looney, Stephen W. ; Pierangdi, Silvia S. ; Harris, E. Nigel. / A retrospective review of 61 patients with antiphospholipid syndrome : Analysis of factors influencing recurrent thrombosis. In: Archives of Internal Medicine. 1997 ; Vol. 157, No. 18. pp. 2101-2108.
@article{80bb325cd3f947ceaf12d4d64f7f47da,
title = "A retrospective review of 61 patients with antiphospholipid syndrome: Analysis of factors influencing recurrent thrombosis",
abstract = "Background: Antiphospholipid syndrome (APS) is a disorder of recurrent venous or arterial thrombosis, pregnancy losses, and thrombocytopenia. Recurrent thrombosis has particularly adverse effects on patient prognosis. The factors that influence recurrence and management techniques that prevent these events remain controversial. To add further insight regarding predisposing factors and the prevention of thrombotic recurrence, 61 well- characterized patients with APS were followed up for a median time of 77 months. Methods: A retrospective cohort study was conducted in which the following factors were examined to determine their influence on thrombotic recurrence: primary vs secondary syndrome; the presence of hypertension, hyperlipidemia, diabetes, or smoking; patient age, sex, and race; pregnancy and oral contraceptives use; and treatment with warfarin sodium, warfarin plus aspirin, aspirin alone, prednisone, or no treatment. Results: There was no difference between patients with primary and secondary APS with respect to recurrent arterial (55{\%} vs 38{\%}, respectively) or recurrent venous (47{\%} vs 50{\%}, respectively) thrombotic events. In all patients with APS, white race (P=.02) was associated with recurrent arterial events. Venous thrombosis occurred during pregnancy or in the postpartum period in 16 (30{\%}) of 53 women and in 8 women taking oral contraceptives. Recurrent arterial and venous thromboses were significantly decreased with prophylactic warfarin use when compared with prednisone use or no treatment. Recurrences were infrequent in patients with prothrombin ratios of 1.5 to 2.0. Conclusions: Treatment with warfarin was most effective in preventing recurrent arterial and venous thrombosis. Pregnancy and the use of oral contraceptives or prednisone may also influence recurrence.",
author = "Sanja Krnic-Barrie and O'Connor, {Carolyn Riester} and Looney, {Stephen W.} and Pierangdi, {Silvia S.} and Harris, {E. Nigel}",
year = "1997",
month = "10",
day = "20",
language = "English (US)",
volume = "157",
pages = "2101--2108",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "18",

}

TY - JOUR

T1 - A retrospective review of 61 patients with antiphospholipid syndrome

T2 - Analysis of factors influencing recurrent thrombosis

AU - Krnic-Barrie, Sanja

AU - O'Connor, Carolyn Riester

AU - Looney, Stephen W.

AU - Pierangdi, Silvia S.

AU - Harris, E. Nigel

PY - 1997/10/20

Y1 - 1997/10/20

N2 - Background: Antiphospholipid syndrome (APS) is a disorder of recurrent venous or arterial thrombosis, pregnancy losses, and thrombocytopenia. Recurrent thrombosis has particularly adverse effects on patient prognosis. The factors that influence recurrence and management techniques that prevent these events remain controversial. To add further insight regarding predisposing factors and the prevention of thrombotic recurrence, 61 well- characterized patients with APS were followed up for a median time of 77 months. Methods: A retrospective cohort study was conducted in which the following factors were examined to determine their influence on thrombotic recurrence: primary vs secondary syndrome; the presence of hypertension, hyperlipidemia, diabetes, or smoking; patient age, sex, and race; pregnancy and oral contraceptives use; and treatment with warfarin sodium, warfarin plus aspirin, aspirin alone, prednisone, or no treatment. Results: There was no difference between patients with primary and secondary APS with respect to recurrent arterial (55% vs 38%, respectively) or recurrent venous (47% vs 50%, respectively) thrombotic events. In all patients with APS, white race (P=.02) was associated with recurrent arterial events. Venous thrombosis occurred during pregnancy or in the postpartum period in 16 (30%) of 53 women and in 8 women taking oral contraceptives. Recurrent arterial and venous thromboses were significantly decreased with prophylactic warfarin use when compared with prednisone use or no treatment. Recurrences were infrequent in patients with prothrombin ratios of 1.5 to 2.0. Conclusions: Treatment with warfarin was most effective in preventing recurrent arterial and venous thrombosis. Pregnancy and the use of oral contraceptives or prednisone may also influence recurrence.

AB - Background: Antiphospholipid syndrome (APS) is a disorder of recurrent venous or arterial thrombosis, pregnancy losses, and thrombocytopenia. Recurrent thrombosis has particularly adverse effects on patient prognosis. The factors that influence recurrence and management techniques that prevent these events remain controversial. To add further insight regarding predisposing factors and the prevention of thrombotic recurrence, 61 well- characterized patients with APS were followed up for a median time of 77 months. Methods: A retrospective cohort study was conducted in which the following factors were examined to determine their influence on thrombotic recurrence: primary vs secondary syndrome; the presence of hypertension, hyperlipidemia, diabetes, or smoking; patient age, sex, and race; pregnancy and oral contraceptives use; and treatment with warfarin sodium, warfarin plus aspirin, aspirin alone, prednisone, or no treatment. Results: There was no difference between patients with primary and secondary APS with respect to recurrent arterial (55% vs 38%, respectively) or recurrent venous (47% vs 50%, respectively) thrombotic events. In all patients with APS, white race (P=.02) was associated with recurrent arterial events. Venous thrombosis occurred during pregnancy or in the postpartum period in 16 (30%) of 53 women and in 8 women taking oral contraceptives. Recurrent arterial and venous thromboses were significantly decreased with prophylactic warfarin use when compared with prednisone use or no treatment. Recurrences were infrequent in patients with prothrombin ratios of 1.5 to 2.0. Conclusions: Treatment with warfarin was most effective in preventing recurrent arterial and venous thrombosis. Pregnancy and the use of oral contraceptives or prednisone may also influence recurrence.

UR - http://www.scopus.com/inward/record.url?scp=0030924102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030924102&partnerID=8YFLogxK

M3 - Article

C2 - 9382667

AN - SCOPUS:0030924102

VL - 157

SP - 2101

EP - 2108

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 18

ER -